Company:  CUE BIOPHARMA, INC. (CUE)
Form Type:  S-8
Filing Date:  3/14/2019 
CIK:  0001645460 
Address:  21 ERIE STREET 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  617-949-2680 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.65  
Change: 
-0.64 (-6.89%)  
Trade Time: 
Mar 21  
Market Cap: 
$179.35M
Trade CUE now with 

© 2019  
Description of Business
Cue Biopharma is a biopharmaceutical company dedicated to designing and developing a novel and proprietary class of biologic product candidates engineered to selectively modulate the human immune system. Our Immuno-STAT(TM) (Selective Targeting and Alteration of T Cells) platform enables us to engineer product candidates that we call Immuno-STATs(TM) or Immuno-STAT biologics(TM) that directly engage with and direct the activity of antigen specific T cells in a patient's body through a singular molecular framework. We believe this precise targeting of disease relevant T cells will allow us to harness the fullest potential of an individual's intrinsic immune repertoire while avoiding broad immune activation (for immuno-oncology or infectious immunity) or broad immune suppression (for autoimmunity and inflammation).
Register and access this filing in:     
  FORM S-8
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE
    PART I
      Item 1. Plan Information.
      Item 2. Registrant Information and Employee Plan Annual ...
    PART II
      Item 3. Incorporation of Documents by Reference.
    Item 4. Description of Securities.
    Item 5. Interests of Named Experts and Counsel.
      Item 6. Indemnification of Directors and Officers.
      Item 7. Exemption from Registration Claimed.
      Item 8. Exhibits.
      Item 9. Undertakings.
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 23.2
    Consent of Independent Registered Public Accounting Firm